DE60238075D1 - Adjuvierte antigene meningokokkenzusammensetzungen - Google Patents

Adjuvierte antigene meningokokkenzusammensetzungen

Info

Publication number
DE60238075D1
DE60238075D1 DE60238075T DE60238075T DE60238075D1 DE 60238075 D1 DE60238075 D1 DE 60238075D1 DE 60238075 T DE60238075 T DE 60238075T DE 60238075 T DE60238075 T DE 60238075T DE 60238075 D1 DE60238075 D1 DE 60238075D1
Authority
DE
Germany
Prior art keywords
meningococcar
adjuvated
antigenic
compositions
meningococcar compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60238075T
Other languages
English (en)
Inventor
Mariagrazia Pizza
Marzia Monica Giuliani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GSK Vaccines SRL
Original Assignee
Novartis Vaccines and Diagnostics SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Vaccines and Diagnostics SRL filed Critical Novartis Vaccines and Diagnostics SRL
Application granted granted Critical
Publication of DE60238075D1 publication Critical patent/DE60238075D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55544—Bacterial toxins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60238075T 2001-12-04 2002-12-04 Adjuvierte antigene meningokokkenzusammensetzungen Expired - Lifetime DE60238075D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0129007.1A GB0129007D0 (en) 2001-12-04 2001-12-04 Adjuvanted antigenic meningococcal compositions
PCT/IB2002/005662 WO2003047619A2 (en) 2001-12-04 2002-12-04 Adjuvanted antigenic meningococcal compositions

Publications (1)

Publication Number Publication Date
DE60238075D1 true DE60238075D1 (de) 2010-12-02

Family

ID=9926977

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60238075T Expired - Lifetime DE60238075D1 (de) 2001-12-04 2002-12-04 Adjuvierte antigene meningokokkenzusammensetzungen

Country Status (11)

Country Link
US (2) US20060008476A1 (de)
EP (1) EP1448230B1 (de)
JP (2) JP4414226B2 (de)
AP (1) AP2004003074A0 (de)
AT (1) ATE485055T1 (de)
AU (1) AU2002353417A1 (de)
CA (1) CA2468935C (de)
CY (1) CY1111114T1 (de)
DE (1) DE60238075D1 (de)
GB (1) GB0129007D0 (de)
WO (1) WO2003047619A2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9513371D0 (en) * 1995-06-30 1995-09-06 Biocine Spa Immunogenic detoxified mutant toxins
PT1947187E (pt) * 2000-02-28 2011-07-04 Novartis Vaccines & Diagnostic Expressões híbridas de proteínas de neisseria
KR100898648B1 (ko) * 2001-06-07 2009-05-22 와이어쓰 홀딩스 코포레이션 보조제로서 콜레라 홀로톡신의 돌연변이체 형태
MX339524B (es) 2001-10-11 2016-05-30 Wyeth Corp Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
WO2003094960A2 (en) * 2002-05-14 2003-11-20 Chiron Srl Mucosal combination vaccines for bacterial meningitis
GB0302218D0 (en) 2003-01-30 2003-03-05 Chiron Sri Vaccine formulation & Mucosal delivery
GB0227346D0 (en) * 2002-11-22 2002-12-31 Chiron Spa 741
ATE506963T1 (de) * 2003-10-02 2011-05-15 Novartis Vaccines & Diagnostic Kombinationsimpfstoffe gegen meningitis
EP2411048B1 (de) 2009-03-24 2020-05-06 GlaxoSmithKline Biologicals SA Adjuvantierendes meningokokken-faktor-h-bindungsprotein
EP3831406B1 (de) 2010-08-23 2024-06-05 Wyeth LLC Stabile formulierungen von neisseria-meningitidis-rlp2086-antigenen
AU2011300409B2 (en) 2010-09-10 2015-03-26 Wyeth Llc Non-lipidated variants of Neisseria meningitidis ORF2086 antigens
US20130287808A1 (en) * 2010-11-05 2013-10-31 Institut National De La Sante Et De La Recherche Medicale (Inserm) Vaccines for preventing meningococcal infections
GB201102090D0 (en) * 2011-02-08 2011-03-23 Univ Sheffield Antigenic polypeptide
SA115360586B1 (ar) 2012-03-09 2017-04-12 فايزر انك تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
MX351993B (es) 2012-03-09 2017-11-03 Pfizer Composiciones de neisseria meningitidis y metodos de las mismas.
US10000545B2 (en) 2012-07-27 2018-06-19 Institut National De La Sante Et De La Recherche Medicale CD147 as receptor for pilus-mediated adhesion of Meningococci to vascular endothelia
CA2903716C (en) 2013-03-08 2019-04-09 Pfizer Inc. Immunogenic fusion polypeptides
MX369534B (es) 2013-09-08 2019-11-11 Pfizer Composiciones de neisseria meningitidis y sus metodos.
RU2723045C2 (ru) 2015-02-19 2020-06-08 Пфайзер Инк. Композиции neisseria meningitidis и способы их получения
JP7010961B2 (ja) 2017-01-31 2022-02-10 ファイザー・インク 髄膜炎菌組成物およびその方法
SG11202106494RA (en) * 2018-12-21 2021-07-29 Univ Griffith Compositions, methods and uses for eliciting an immune response
WO2021067628A2 (en) * 2019-10-01 2021-04-08 Beth Israel Deaconess Medical Center, Inc. Conformation-specific antibodies that bind nuclear factor kappa-light-chain-enhancer of activated b cells

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5153312A (en) * 1990-09-28 1992-10-06 American Cyanamid Company Oligosaccharide conjugate vaccines
AU9363798A (en) * 1997-11-06 1999-05-31 Chiron S.P.A. Neisserial antigens
GB9726398D0 (en) * 1997-12-12 1998-02-11 Isis Innovation Polypeptide and coding sequences
SG152917A1 (en) * 1998-01-14 2009-06-29 Chiron Srl Neisseria meningitidis antigens
JP4673974B2 (ja) * 1998-09-30 2011-04-20 ワイス・ホールディングズ・コーポレイション アジュバントとしての変異コレラホロトキシン
US7384640B1 (en) * 1999-09-30 2008-06-10 Wyeth Holdings Corporation Mutant cholera holotoxin as an adjuvant
AR045702A1 (es) * 2001-10-03 2005-11-09 Chiron Corp Composiciones de adyuvantes.

Also Published As

Publication number Publication date
AP2004003074A0 (en) 2004-06-30
JP4414226B2 (ja) 2010-02-10
WO2003047619A2 (en) 2003-06-12
CA2468935A1 (en) 2003-06-12
EP1448230B1 (de) 2010-10-20
JP2005511662A (ja) 2005-04-28
ATE485055T1 (de) 2010-11-15
CY1111114T1 (el) 2015-06-11
WO2003047619A3 (en) 2003-10-23
JP2009155344A (ja) 2009-07-16
AU2002353417A1 (en) 2003-06-17
US20100233205A1 (en) 2010-09-16
CA2468935C (en) 2013-02-05
GB0129007D0 (en) 2002-01-23
US20060008476A1 (en) 2006-01-12
EP1448230A2 (de) 2004-08-25

Similar Documents

Publication Publication Date Title
DE60238075D1 (de) Adjuvierte antigene meningokokkenzusammensetzungen
ATE553775T1 (de) Impstoffzusammesetzung
NO20026175L (no) Vaksinesammensetning
ATE420159T1 (de) Grippe-impfstoffzusammensetzung
ATE303787T1 (de) Schergelzusammensetzungen
DE60027029D1 (de) Kombinierte impfstoffzusammensetzungen
FI20010780A0 (fi) Parannetut koostumukset
IS6915A (is) Lyfjablanda
DK1427444T3 (da) West-nil-vaccine
DE50208621D1 (de) Turbomaschine
DE50201677D1 (de) Farbmittelkomposition
BR0210619A (pt) composição
DE50112625D1 (de) Turbomaschine
NO20033882D0 (no) Vaksine
IS7081A (is) Lyfjablanda
ATE314049T1 (de) Schweisshemmende zusammensetzungen
EE200300569A (et) CD44v6-spetsiifilised antikehad
DE50206249D1 (de) Turbomaschine
ZA200401211B (en) Antigenic compositions
ITMI20022613A1 (it) Filatoio
ITTO20020747A0 (it) Composizione
ITMI20022486A1 (it) Filatoio
DE60220235D1 (de) Optimierte teilchenförmige Zusammensetzungen
ITTO20020745A0 (it) Composizione
EE200300377A (et) Loomulikud HI-viiruse vastased antikehad